EpiBone is a pioneering regenerative medicine company at the forefront of bone and cartilage repair. Leveraging the power of stem cells, biomimicry, and 3D fabrication, they are developing a pipeline of innovative products with enormous potential to revolutionize orthopedic repair. Their lead product, a living, anatomically precise 3D bone graft, completed its Phase I/IIa clinical trial in August 2023. The rest of their pipeline focuses on cartilage repair, and includes an allogeneic osteochondral plug, whose IND was approved in July 2023. Their cartilage portfolio also includes an injectable cartilage filler that was partly funded by the Department of Defense.

Jersey City, NJ, USA

Brooklyn, NY, USA

EpiBone

The Cedars-Sinai Accelerator helps today's technology innovators turn their ideas into breakthroughs. #CSAccelerator

Cedars-Sinai Accelerator

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Cedars-Sinai Accelerator Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Cedars-Sinai Accelerator network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Cedars-Sinai Accelerator company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Work for companies that improve the lives of healthcare professionals and patients